In vivo changes in canine ventricular cardiac conduction during halothane anesthesia

Area of Science:

• Cardiology
• Anesthesiology
• Electrophysiology

Background:

• Halothane is a common anesthetic agent.
• Its effects on the cardiac ventricular conduction system require further elucidation.
• Understanding these effects is crucial for patient safety during anesthesia.

Purpose of the Study:

• To investigate the electrophysiological changes in the canine ventricular conduction system induced by halothane anesthesia.
• To assess the impact of varying halothane concentrations on conduction times and refractory periods.

Main Methods:

• Utilized His bundle recording, pacing, and premature stimulation in a canine model.
• Administered halothane at different concentrations (1.5% and 2.4%) or with thiopental.
• Measured epicardial activation times and ventricular functional and effective refractory periods.

Main Results:

• Increased halothane concentration (1.5% to 2.4%) significantly prolonged epicardial activation times and decreased ventricular functional refractory periods.
• Effective refractory period of the ventricular conduction system did not change, but epicardial conduction delays at this period decreased.
• Addition of 1.5% halothane to thiopental decreased the effective refractory period and increased epicardial conduction delays.

Conclusions:

• Halothane anesthesia, particularly at higher concentrations, depresses ventricular conduction and shortens refractory periods in the ventricular conduction system.
• Findings align with in vitro studies on halothane's effects on Purkinje fibers.
• Results highlight potential in vivo electrophysiological consequences of halothane use in canines.